Comparison of the Effect of Intravenous Dexmedetomidine and Midazolam on Hemodynamic and Respiratory Mechanic in Patients under Mechanical Ventilation in the Intensive care unit of Bandar Abbas Shahid Mohammadi Hospital, 2020
Iranian Journal of Emergency Medicine,
Vol. 9 No. 1 (2022),
16 March 2022
,
Page e9
https://doi.org/10.22037/ijem.v9i1.38379
Abstract
Introduction: It remains a challenge to provide optimal sedation for patients on mechanical ventilation in ICU. Traditionally, Midazolam has been the most commonly administered sedative drug for ICU patients worldwide. Dexmedetomidine is a newer sedative used for ICU sedation having better hemodynamic stability and no respiratory depressant effect.
Methods: This was a parallel randomized, double-blind study. Study population was intensive care unit patients undergoing mechanical ventilation. All the 33 patients received 1 μg/kg IV dexmedetomidine over 10 minutes followed by a maintenance infusion of 0.5 μg/kg/h dexmedetomidine. After 24 hours patients received 0.05 mg/kg midazolam followed by a maintenance infusion of 0.1 mg/kg/h. The dosage of sedative was changed according to the outcome of maintaining a target sedation level of RASS 0 to -1. The cardiovascular and ABG parameters and quality of ventilation were measured at baseline, 12 and 24 hours after sedation.
Results: 28 patients (84.8%) were men and 5 (15.2) were women. The mean age of the patients was 36.12±69.74 years. Systolic blood pressure (P<0.005), diastolic blood pressure (P=0.003), mean arterial pressure (P=0.02) and heart rate (P=0.003) were significantly higher in Midazolam group at 24 hours. In addition, O2 saturation was significantly different between dexmedetomidine and midazolam at 12 hours (P=0.03) and 24 hours (P=0.001). ABG parameters were similar between two sedatives.
Conclusions: The results of this study showed that dexmedetomidine has better hemodynamic effects than midazolam. Also, the effects of dexmedetomidine and Midazolam on lung mechanics are the same.
- midazolam
- dexmedetomidine
- mechanical ventilation
How to Cite
References
Brook AD, Ahrens TS, Schaiff R, Prentice D, Sherman G, Shannon W, et al. Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Critical care medicine. 1999;27(12):2609-15.
Kress JP, Pohlman AS, O'Connor MF, Hall JB. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. New England Journal of Medicine. 2000;342(20):1471-7.
Sydow M, Neumann P. Sedation for the critically ill. Intensive care medicine. 1999;25(6):634-6.
Martin J, Franck M, Fischer M, Spies C. Sedation and analgesia in German intensive care units: how is it done in reality? Results of a patient-based survey of analgesia and sedation. Intensive care medicine. 2006;32(8):1137-42.
Jacobi J. Task Force of the American College of Critical Care Medicine (ACCM) of the Society of Critical Care Medicine (SCCM), American Society of Health-System Pharmacists (ASHP), American College of Chest Physicians. Clinical practice guidelines or the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med. 2002;30:119-41.
Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology: The Journal of the American Society of Anesthesiologists. 2000;93(2):382-94.
McMorrow SP, Abramo TJ. Dexmedetomidine sedation: uses in pediatric procedural sedation outside the operating room. Pediatric emergency care. 2012;28(3):292-6.
Fernandes FC, Ferreira HC, Cagido VR, Carvalho GM, Pereira LS, Faffe DS, et al. Effects of dexmedetomidine on respiratory mechanics and control of breathing in normal rats. Respiratory physiology & neurobiology. 2006;154(3):342-50.
Lee SH, Kim N, Lee CY, Ban MG, Oh YJ. Effects of dexmedetomidine on oxygenation and lung mechanics in patients with moderate chronic obstructive pulmonary disease undergoing lung cancer surgery: A randomised double-blinded trial. Eur J Anaesthesiol. 2016;33(4):275-82.
Barros Heil LB, Santos CL, Santos RS, Samary CS, Cavalcanti V, Araújo MM, et al. The effects of short-term propofol and dexmedetomidine on lung mechanics, histology, and biological markers in experimental obesity. Anesthesia & Analgesia. 2016;122(4):1015-23.
Pandharipande PP, Pun BT, Herr DL, Maze M, Girard TD, Miller RR, et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. Jama. 2007;298(22):2644-53.
Maldonado JR, Wysong A, Van Der Starre PJ, Block T, Miller C, Reitz BA. Dexmedetomidine and the reduction of postoperative delirium after cardiac surgery. Psychosomatics. 2009;50(3):206-17.
Spencer E, Willatts S. Isoflurane for prolonged sedation in the intensive care unit; efficacy and safety. Intensive care medicine. 1992;18(7):415-21.
Huang Z, Chen Y-s, Yang Z-l, Liu J-y. Dexmedetomidine versus midazolam for the sedation of patients with non-invasive ventilation failure. Internal medicine. 2012;51(17):2299-305.
Elgebaly AS, Sabry M. Sedation effects by dexmedetomidine versus propofol in decreasing duration of mechanical ventilation after open heart surgery. Ann Card Anaesth. 2018;21(3):235-42.
Srivastava VK, Agrawal S, Kumar S, Mishra A, Sharma S, Kumar R. Comparison of dexmedetomidine, propofol and midazolam for short-term sedation in postoperatively mechanically ventilated neurosurgical patients. Journal of Neuroanaesthesiology and Critical Care. 2015;02(02):A24.
Shi Z-G, Mi W-D. Application of dexmedetomidine for lung injury in elderly patients undergoing one-lung ventilation. Archives of Medical Science. 2019;16(1):1-8.
Said A, Sabry M. Sedation effects by dexmedetomidine versus propofol in decreasing duration of mechanical ventilation after open heart surgery. Ann Card Anaesth. 2018;21(3):235-42.
- Abstract Viewed: 174 times
- pdf (فارسی) Downloaded: 153 times